Li S, Wang X, Liu L, Liu J, et al. CD7 targeted "off-the-shelf" CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies. Leukemia 2023;37:2176-2186.
PMID: 37700087